Cenduit Launches New Professional Services Division to Provide Seamless User Experience

February 11, 2016
Division provides total solution for smoother, more efficient trials

RESEARCH TRIANGLE PARK, NC, UNITED STATES - Feb 11, 2016 - Cenduit Launches New Professional Services Division to Provide Seamless User Experience

Division provides total solution for smoother, more efficient trials

Research Triangle Park, NC - February 11, 2016 -Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, today announced the launch of its new Professional Services Division. Expanding its commitment to customers, Cenduit created this group to establish a new operating model that engages sponsors throughout the entire clinical trial and provides hands-on experience when it comes to managing and enhancing Interactive Response Technology (IRT) systems.

As the world’s largest IRT specialist, Cenduit has deep expertise in clinical domain, IRT system integration and people across multiple vendors, CROs and sponsors. Promoting collaboration across its IRT services and platforms, Cenduit’s Professional Services Division encompasses research and development, enables more effective patient and drug management, provides eClinical integration, BI Analytics and solutions for customization to provide a seamless user experience.

“The Cenduit Professional Services Division goes above and beyond for its clients by working together with our sales, project management and operations teams to create a customized system that exceeds the expectations of the original design plan,” said Praveen Chand, director of professional services, Cenduit. “I am excited to be heading up this team that was created to keep sponsors as the focal point, providing a total solution that makes the IRT process dramatically smoother and more efficient, with innovative solutions and quality product delivery - from study build through maintenance and closeout.”

In addition to the collaboration between various business functions at Cenduit, the Professional Services Division will also weigh in on particularly complex protocols or integrations with third-party systems that may require extra support to achieve trial success. The new division will also manage Cenduit’s custom reporting tool to accommodate complex reporting requests that project management may need to fulfill for a client.

“Professional Services is another tool in Cenduit’s toolkit, available to jump into study build or maintenance as-needed, providing one-off support for particularly challenging requests where additional expertise and resources are needed,” added Chand.  

How Cenduit’s Professional Services Division will benefit clients:

  • Providing support with complex third-party system integrations and customizations
  • Consulting for complex studies that require focused support
  • Protocol-specific consulting (for example, needing an IVR set up where the patient will call in and report adverse events)
  • Business analytics and reporting such as forecasting dashboard, enabling with effective decision support system for optimization.

 

About Cenduit

Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is the largest IRT specialist in the world with the expertise to empower sponsors for success by implementing a completely personalized system that puts them in control of their clinical trials. With the needs of investigator sites and patients top of mind, Cenduit offers clinical supply chain intelligence and clinical operations know-how through its IRT-driven services: patient randomization, patient reminders, drug supply management, and eClinical integration. Cenduit has offices in the US, UK, Switzerland, India, and Japan, and global clinical trial experience in more than 100 countries, interacting with more than 600,000 patients at more than 32,000 sites. For additional information, visit Cenduit online at www.cenduit.com; on Twitter @CenduitLLC or on LinkedIn at www.LinkedIn.com/Company/Cenduit.